Agilyx (AGLX) H2 2025 earnings summary

Executive summary

• Reported a significant net loss of $132.5 million for the six months ended December 31, 2025, primarily driven by impairments and losses from equity-accounted associates.

• Total assets stood at $106.7 million as of December 31, 2025, with cash and cash equivalents of $44.3 million.

Financial highlights

• Operating revenue for the period was $822,793, with a gross margin loss of $1.7 million.

• Operating loss reached $6.8 million, while net financial items contributed a further $118.9 million in losses.

• Impairment charges included $98.6 million for equity-accounted associates and $26.7 million for subsidiaries.

• Net cash used in operations was $8.6 million; net cash from financing activities was $24.1 million.

Outlook and guidance

• No explicit forward-looking guidance provided, but significant impairments and losses suggest ongoing financial challenges.